Variability in Asthma Inflammatory Phenotype in Induced Sputum. Frequency and Causes;Variabilidad del fenotipo inflamatorio del asma en el esputo inducido. Frecuencia y causas

Archivos de Bronconeumologia

Volumn 52, Issue 2, 2016, Pages 76-81

  Suárez Cuartín, Guillermo ^a   Crespo, Astrid ^a   Mateus, Eder ^a   Torrejón, Montserrat ^a   Giner, Jordi ^a   Belda, Alicia ^a   Ramos Barbón, David ^a   Torrego, Alfons ^a   Plaza, Vicente ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Asthma; Eosinophils; Induced sputum; Neutrophils; Phenotype

Indexed keywords

ARTICLE; ASTHMA; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE EXACERBATION; EOSINOPHIL; GRANULOCYTE; HUMAN; MAJOR CLINICAL STUDY; NEUTROPHIL; OBSERVATIONAL STUDY; PAUCIGRANULOCYTE; PHENOTYPIC VARIATION; RETROSPECTIVE STUDY; RISK FACTOR; SMOKING; SPUTUM ANALYSIS; ADOLESCENT; ADULT; AGED; CYTOLOGY; GENETICS; IMMUNOLOGY; MIDDLE AGED; PHENOTYPE; SPUTUM; VERY ELDERLY; YOUNG ADULT; CAUSAL ATTRIBUTION; CLINICAL FEATURE; DEMOGRAPHY; EOSINOPHILIA; FEMALE; GRANULOCYTOPENIA; MALE; NEUTROPHILIA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ASTHMA; EOSINOPHILS; HUMANS; MIDDLE AGED; NEUTROPHILS; PHENOTYPE; RETROSPECTIVE STUDIES; SPUTUM; YOUNG ADULT;

EID: 84955694707     PISSN: 03002896     EISSN: 15792129     Source Type: Journal    
DOI: 10.1016/j.arbres.2015.03.007     Document Type: Article

References (40)

1. Chung K.F., Wenzel S.E., Brozek J.L., Bush A., Castro M., Sterk P.J., et al. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma. Eur Respir J. 2014, 43:343-373.
2. Wenzel S.E. Asthma phenotypes: the evolution from clinical to molecular approaches. Nat Med. 2012, 18:716-725.
3. Davies A.R., Hancox R.J. Induced sputum in asthma: diagnostic and therapeutic implications. Curr Opin Pulm Med. 2013, 19:60-65.
4. Guía Española para el Manejo del Asma (GEMA 2009). Arch Bronconeumol. 2009;45 (Suppl 2):1-35. Disponible en: . http://www.gemasma.com/.
5. Simpson J.L., Scott R., Boyle M.J., Gibson P.G. Inflammatory subtypes in asthma: assessment and identification using induced sputum. Respirology. 2006, 11:54-61.
6. Pavord I.D., Brightling C.E., Woltmann G., Wardlaw A.J. Non-eosinophilic corticosteroid unresponsive asthma. Lancet. 1999, 353:2213-2214.
7. Berry M., Morgan A., Shaw D.E., Parker D., Green R., Brightling C., et al. Pathological features and inhaled corticosteroid response of eosinophilic and non-eosinophilic asthma. Thorax. 2007, 62:1043-1049.
8. Simpson J.L., Powell H., Boyle M.J., Scott R.J., Gibson P.G. Clarithromycin targets neutrophilic airway inflammation in refractory asthma. Am J Respir Crit Care Med. 2008, 177:148-155.
9. Iwamoto H., Yokoyama A., Shiota N., Shoda H., Haruta Y., Hattori N., et al. Tiotropium bromide is effective for severe asthma with noneosinophilic phenotype. Eur Respir J. 2008, 31:1379-1380.
10. Kraft M., Djukanovic R., Wilson S., Holgate S.T., Martin R.J. Alveolar tissue inflammation in asthma. Am J Respir Crit Care Med. 1996, 154:1505-1510.
11. Pavord I.D., Sterk P.J., Hargreave F.E., Kips J.C., Inman M.D., Louis R., et al. Clinical applications of assessment of airway inflammation using induced sputum. Eur Respir J Suppl. 2002, 37:40s-43s.
12. Louis R., Lau L.C., Bron A.O., Roldaan A.C., Radermecker M., Djukanovic R. The relationship between airways inflammation and asthma severity. Am J Respir Crit Care Med. 2000, 161:9-16.
13. Al-Samri M.T., Benedetti A., Prefontaine D., Olivenstein R., Lemiere C., Nair P., et al. Variability of sputum inflammatory cells in asthmatic patients receiving corticosteroid therapy: A prospective study using multiple samples. J Allergy Clin Immunol. 2010, 125:1161-1163.
14. Fleming L., Tsartsali L., Wilson N., Regamey N., Bush A. Sputum inflammatory phenotypes are not stable in children with asthma. Thorax. 2012, 67:675-681.
15. Van Veen I.H., Ten B.A., Gauw S.A., Sterk P.J., Rabe K.F., Bel E.H. Consistency of sputum eosinophilia in difficult-to-treat asthma: a 5-year follow-up study. J Allergy Clin Immunol. 2009, 124:615-617. 617.
16. Haldar P., Pavord I.D. Noneosinophilic asthma: a distinct clinical and pathologic phenotype. J Allergy Clin Immunol. 2007, 119:1043-1052.
17. Green R.H., Brightling C.E., McKenna S., Hargadon B., Parker D., Bradding P., et al. Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial. Lancet. 2002, 360:1715-1721.
18. Global Strategy for Asthma Management and Prevention. Global Initiative for Asthma (GINA) 2014. [consultado 15 Sep 2014]. Disponible en: . http://www.ginasthma.org/.
19. Vega J.M., Badia X., Badiola C., Lopez-Vina A., Olaguibel J.M., Picado C., et al. Validation of the Spanish version of the Asthma Control Test (ACT). J Asthma. 2007, 44:867-872.
20. Reddel H.K., Taylor D.R., Bateman E.D., Boulet L.P., Boushey H.A., Busse W.W., et al. An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice. Am J Respir Crit Care Med. 2009, 180:59-99.
21. Bernstein I.L., Li J.T., Bernstein D.I., Hamilton R., Spector S.L., Tan R., et al. Allergy diagnostic testing: an updated practice parameter. Ann Allergy Asthma Immunol. 2008, 100(3 Suppl 3):S1-S148.
22. Garcia-Rio F., Calle M., Burgos F., Casan P., Del C.F., Galdiz J.B., et al. Spirometry. Spanish Society of Pulmonology and Thoracic Surgery (SEPAR). Arch Bronconeumol. 2013, 49:388-401.
23. Roca J., Sanchis J., Agusti-Vidal A., Segarra F., Navajas D., Rodriguez-Roisin R., et al. Spirometric reference values from a Mediterranean population. Bull Eur Physiopathol Respir. 1986, 22:217-224.
24. ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. Am J Respir Crit Care Med. 2005, 171:912-930.
25. Dweik R.A., Boggs P.B., Erzurum S.C., Irvin C.G., Leigh M.W., Lundberg J.O., et al. An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications. Am J Respir Crit Care Med. 2011, 184:602-615.
26. Pizzichini E., Pizzichini M.M., Efthimiadis A., Evans S., Morris M.M., Squillace D., et al. Indices of airway inflammation in induced sputum: reproducibility and validity of cell and fluid-phase measurements. Am J Respir Crit Care Med. 1996, 154:308-317.
27. McGrath K.W., Icitovic N., Boushey H.A., Lazarus S.C., Sutherland E.R., Chinchilli V.M., et al. A large subgroup of mild-to-moderate asthma is persistently noneosinophilic. Am J Respir Crit Care Med. 2012, 185:612-619.
28. D'silva L., Cook R.J., Allen C.J., Hargreave F.E., Parameswaran K. Changing pattern of sputum cell counts during successive exacerbations of airway disease. Respir Med. 2007, 101:2217-2220.
29. Kupczyk M., Dahlén B., Sterk P.J., Nizankowska-Mogilnicka E., Papi A., Bel E.H., et al. Stability of phenotypes defined by physiological variables and biomarkers in adults with asthma. Allergy. 2014, 69:1198-1204.
30. Green R.H., Pavord I. Stability of inflammatory phenotypes in asthma. Thorax. 2012, 67:665-667.
31. Schleich F.N., Manise M., Sele J., Henket M., Seidel L., Louis R. Distribution of sputum cellular phenotype in a large asthma cohort: predicting factors for eosinophilic vs neutrophilic inflammation. BMC Pulm Med. 2013, 13:11.
32. Chalmers G.W., MacLeod K.J., Thomson L., Little S.A., McSharry C., Thomson N.C. Smoking and airway inflammation in patients with mild asthma. Chest. 2001, 120:1917-1922.
33. Thomson N.C., Chaudhuri R. Asthma in smokers: challenges and opportunities. Curr Opin Pulm Med. 2009, 15:39-45.
34. Wark P.A., Johnston S.L., Moric I., Simpson J.L., Hensley M.J., Gibson P.G. Neutrophil degranulation and cell lysis is associated with clinical severity in virus-induced asthma. Eur Respir J. 2002, 19:68-75.
35. Singh A.M., Moore P.E., Gern J.E., Lemanske R.F., Hartert T.V. Bronchiolitis to asthma: a review and call for studies of gene-virus interactions in asthma causation. Am J Respir Crit Care Med. 2007, 175:108-119.
36. Pizzichini M.M., Pizzichini E., Clelland L., Efthimiadis A., Mahony J., Dolovich J., et al. Sputum in severe exacerbations of asthma: kinetics of inflammatory indices after prednisone treatment. Am J Respir Crit Care Med. 1997, 155:1501-1508.
37. Jatakanon A., Kharitonov S., Lim S., Barnes P.J. Effect of differing doses of inhaled budesonide on markers of airway inflammation in patients with mild asthma. Thorax. 1999, 54:108-114.
38. Petsky H.L., Cates C.J., Lasserson T.J., Li A.M., Turner C., Kynaston J.A., et al. A systematic review and meta-analysis: tailoring asthma treatment on eosinophilic markers (exhaled nitric oxide or sputum eosinophils). Thorax. 2012, 67:199-208.
39. Van Rensen E.L., Straathof K.C., Veselic-Charvat M.A., Zwinderman A.H., Bel E.H., Sterk P.J. Effect of inhaled steroids on airway hyperresponsiveness, sputum eosinophils, and exhaled nitric oxide levels in patients with asthma. Thorax. 1999, 54:403-408.
40. Cowan D.C., Cowan J.O., Palmay R., Williamson A., Taylor D.R. Effects of steroid therapy on inflammatory cell subtypes in asthma. Thorax. 2010, 65:384-390.